Unfavourable risk factor control after coronary events in routine clinical practice
Elise Sverre(University of Oslo), John Munkhaugen(University of Oslo), Kari Peersen(Oslo University Hospital), Torbjørn Moum(University of Oslo), Einar Husebye(Drammen Hospital), Erik Gjertsen(Drammen Hospital), Lars Gullestad(Apple (Israel)), Jan Erik Otterstad(Sykehuset i Vestfold), Toril Dammen(Oslo University Hospital)
Cited by 31
Related Papers
Rosuvastatin in Older Patients with Systolic Heart Failure
|New England Journal of Medicine|2007|1.5k
Atrial fibrillation and the risk for myocardial infarction, all-cause mortality and heart failure: A systematic review and meta-analysis
|European Journal of Preventive Cardiology|2017|402
Polymorphisms at codons 141 and 154 in the ovine prion protein gene are associated with scrapie Nor98 cases
|Journal of General Virology|2004|244
Prehypertension, Obesity, and Risk of Kidney Disease: 20-Year Follow-up of the HUNT I Study in Norway
|American Journal of Kidney Diseases|2009|156
Effect of oral β-blocker treatment on mortality in contemporary post-myocardial infarction patients: a systematic review and meta-analysis
|European Heart Journal - Cardiovascular Pharmacotherapy|2018|121